InflaRx Will Focus Development Activities And Resources Initially On Selected Indications In Immuno-dermatology, With Registrational-phase Vilobelimab And INF904
InflarX 最初將開發活動和資源集中在免疫皮膚病學的特定適應症上,包括註冊階段 Vilobelimab 和 INF904
InflaRx Will Focus Development Activities And Resources Initially On Selected Indications In Immuno-dermatology, With Registrational-phase Vilobelimab And INF904
InflarX 最初將開發活動和資源集中在免疫皮膚病學的特定適應症上,包括註冊階段 Vilobelimab 和 INF904
使用瀏覽器的分享功能,分享給你的好友吧